NFE2L2 and hepatocellular carcinoma: The resultant metabolites of arachidonic acid by the rate-limiting enzyme COX2, that also serves as a direct target of Nrf2 [57,58], are much likely to play a crucial role in development and progression of inflammation, particularly NASH and hepatoma caused by knockout of Nrf1α−/−.